SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?


To: Anthony Wong who wrote (6087)10/16/1998 1:15:00 PM
From: Anthony Wong  Read Replies (1) | Respond to of 9523
 
PaineWebber on Monsanto & Celebrex (10/16/98)[thanks to Henry Niman]

MONSANTO: 3Q98 EPS IN LINE WITH EXPECTATIONS
Paine Webber
A. Cash,M. Judd
October 16, 1998

PW PW PW PW PW PaineWebber PW PW PW PW PW

Rating=3 (MTC)
Closing Price=$37
Current FY EPS EST=$0.95
Next FY EPS EST=$1.10
FY End=December

10/16/98

KEY POINTS
1. 3Q98 EPS excluding unusual charges was $0.13, which met concensus
expectations. As expected, 3Q98 EPS were greatly bolstered by a Pfizer's
milestone payment for Celebrex ('Celebra') of $140 million
($0.16/share).
2. Monsanto changed Celebra's name to Celebrex, at the FDA's request.
3. Short-term earnings are not particularly important as attention is
focused on Celebrex's expected FDA approval and launch in 1Q99. Our base
case earnings contribution from Celebrex is $0.55 per share by 2001.
4. During the conference call, the company put off answering questions
about future earnings, preferring to address them in Monday's analyst
meeting in New York.
5. As stated in our last note, we expect the stock to recover towards
$40, having over reacted to the AHP breakup.

PaineWebber note on Celebra on Oct. 14

All eyes on Celebra's FDA approval. Our base case earnings
contribution from Celebra is $0.55 per share by 2001. Eyes also on
closure of pending deals, particularly Dekalb, and the financing of
these deals.
PaineWebber pharmaceutical analyst Jeff Chaffkin forecast that
Celebra could achieve sales of $2 billion in the next few years. The
impact to Monsanto earnings could be over $0.50 per share by 2001. These
figures are all very preliminary, assuming $2.50-3.00 cost per day,
certain demand and an assumed competitive performance against Merck's
anticipated launch of Vioxx.

Copied from Henry Niman's website:
paradise-web.com




To: Anthony Wong who wrote (6087)10/17/1998 10:24:00 AM
From: BigKNY3  Read Replies (1) | Respond to of 9523
 
The 10/11/98 post was updated with improved PFE PForecasts and the following benchmark:

Dow Index (10/16/98): 8,417 (+6.4%)
Predicted PFE : 100.36 (+34.6%)
Actual PFE: 98.44 (+32.0%)

Difference Actual/Prediction: -1.9%
____________________________________

The Peabody Model: The Influence of the Dow (updated: 10/17/98)

One of the basic principles of The Peabody Model is that 80% of the movement of the PFE price is not related to company pfundamentals. 50% is related to the Big Pharma sector environment and 30% is related to the general market as indicated by the Dow Jones. In this post, Mr. Peabody will examine the relationship between PFE and the Dow.

The Data (Updated: 10/16/98)

Did you ever know how PFE was doing by quickly checking the state of the Dow Jones? "Dow up 100, PFE must be up at least 2. Dow down 250, PFE has to be crushed by 3 points." Does history confirm these gut-feel relationships between the direction of PFE and the Dow?

Using the Wayback Machine for the 42 completed weeks in 1998, here are the 1998 weekly closes for the PFE and the Dow, % YTD changes for PFE and the Dow, and the PFE Premium (the YTD PFE change- YTD Dow change):

Max Points

.........Weekly..Weekly...YTD.....YTD.................................
............PFE.....Dow......PFE......Dow.... Premium
...........Close....Close....Chg.......Chg..... PFE/Dow
1/2/98...75.69....7,965....1.5%....0.7%.....0.8%
1/9/98...74.06....7,580....-0.7%...-4.1%....3.5%
1/16/98.77.00....7,753....3.3%.....-2.0%...5.2%
1/23/98.78.06....7,701....4.7%.....-2.6%...7.3%
1/30/98.81.75....7,907....9.6%.....0.0%....9.7%
2/6/98...81.00....8,189....8.6%....3.6%.....5.1%
2/13/98..83.63...8,370....12.2%...5.8%....6.3%
2/20/98..87.31...8,414....17.1%...6.4%....10.7%
2/27/98..88.50...8,546....18.7%...8.1%....10.6%
3/6/98...86.25....8,569....15.7%...8.4%....7.3%
3/13/98..86.00...8,603....15.3%...8.8%....6.6%
3/20/98..92.25...8,906....23.7%...12.6%...11.1%
3/27/98..95.50...8,796....28.1%...11.2%...16.9%
4/3/98...101.69..8,983....36.4%...13.6%...22.8%
4/10/98..99.25...8,995....33.1%...13.7%...19.4%
4/17/98..105.13..9,168...41.0%...15.9%...25.1%
4/24/98..118.00..9,064...58.3%...14.6%...43.6%
5/1/98...112.69..9,147....51.1%...15.7%...35.5%
5/8/98...111.19..9,055....49.1%...14.5%...34.6%
5/15/98..104.44..9,096...40.1%...15.0%...25.0%
5/22/98..105.44..9,114...41.4%...15.3%...26.2%
5/29/98..104.81..8,900...40.6%...12.5%...28.0%
6/5/98...108.38..9,038....45.3%...14.3%...31.1%
6/12/98..109.38..8,835...46.7%...11.7%...35.0%
6/19/98..111.25..8,713...49.2%...10.2%...39.0%
6/26/98..111.94..8,944...50.1%...13.1%...37.0%
7/3/98...107.50..9,025....44.2%...14.1%...30.0%
7/10/98..118.00..9,106....58.3%...15.2%...43.1%
7/17/98 ..115.63..9,338...55.1%...18.1%...37.0%
7/24/98..113.50..8,937...52.2%...13.0%...39.2%
7/31/98..110.06..8,883...47.6%...12.3%...35.3%
8/7/98...103.50..8,598....38.8%...8.7%....30.1%
8/14/98..101.19..8,425...35.7%...6.5%.....29.2%
8/21/98..105.88..8,534...42.0%...7.9%.....34.1%
8/28/98..101.63..8,052...36.3%...1.8%.....34.5%
9/4/98...95.13... 7,640....27.6%...-3.4%....31.0%
9/11/98..100.50..7,796...34.8%...-1.4%....36.2%
9/18/98..97.25...7,896....30.4%...-0.2%....30.6%
9/25/98 ..106.63..8,029....43.0%...1.5%.....41.5%
10/2/98..99.06...7,785....32.9%...-1.6%....34.4%
10/9/98..92.94...7,900....24.6%...-0.1%....24.8%
10/16/98..98.44..8,417....32.0%...+6.4%....25.6%

Total YTD, 1998............32.8%....8.0%....24.8%
2nd Half, 1998 ..............39.7%....6.2%...33.5%

Direction of PFE and the Dow (Updated 10/17/98)

......................................#............% of
Direction.......................Weeks.......Total
PFE/Dow Same Trend.......27.......... 64%
PFE Up/Dow Up................17.......... 40%
PFE Down/Dow Down.........10......... 24%

PFE/Dow Different Trend......15.........36%
PFE Up/Dow Down.............. 5.........12%
PFE Down/Dow Up..............10........ 24%

Total.................................. 42........100%

Average PFE Premium Versus the Dow

..............................Average PFE
Dow Range.................Premium
7,000............................+18.3%
8,000............................+23.8%
9,000............................+33.1%

The Analysis

Changes in the Dow are directed correlated to changes in PFE (r=+.46). As shown above, PFE and the Dow move in the same weekly direction a total of 63% of the time and opposite directions 37% of the time.

Based on a comparison of the weekly YTD growth rates for PFE and the Dow, PFE has an average premium growth rate (YTD PFE growth rate-YTD Dow growth rate) of 24.7% for 1998. For the second half of 1998, this premium was higher (+34.1%). The current PFE Premium (10/09/98) of 24.8% is on par with the 1998 average. The PFE Premium also increases as the Dow increases (7,000=+18.3%, 8,000=+23.1%, 9,000=+33.1%).

The PForecasts

Since PFE and the Dow are significantly correlated, is it possible to estimate PFE prices if you can accurately pforecast the Dow ?.. (Not an easy task!!). Other questions.... if the correlation between PFE and the Dow holds for the rest of 1998, what would you expect the price of PFE to be if the Dow drops to 6,500 or increases to 10,000? Here's an attempt:

The first step in this Model amendment is to pforecast the PFE Premium for weekly close levels below 7,500 and above 9,200...numbers not reached yet in 1998.

Based on the 1998 weekly and using statistical pforecasts, here are the PFE Premiums for a wide range of Dow levels:

.........................Average
Dow Range........PFE Premium
..6,000..................10.3%
..7,000..................18.3%
..8,000..................23.8%
..9,000..................33.1%
10,000..................39.9%
11,000..................47.2%
12,000..................54.6%

Based on the above PFE Premiums, the predicted PFE prices for various Dow levels are as follows:

....................Dow..Predicted......Predicted PFE
Actual.........% Chg...PFE..............% Change
Dow............98/97....Price................98/97
6,000..........-24.1%..64.25..........-13.8%
6,500..........-17.8%..71.72..........-3.8%
7,000..........-11.5%..79.19..........6.2%
7,500..........-5.2%...86.66..........16.2%
8,000..........1.2%....94.13..........26.2%
8,500..........7.5%....101.60.........36.3%
9,000..........13.8%...109.07........46.3%
9,500..........20.1%...116.54........56.3%
10,000........26.5%...124.01........66.3%
10,500........32.8%....131.48.......76.3%
11,000........39.1%...138.94........86.3%
11,500........45.4%...146.41........96.4%
12,000........51.7%...153.88........106.4%

As shown above, the model indicates that for PFE to reach 124 (+66%), the Dow will need to increase to 10,000, a 27% increase over 1997. Moreover, if the Dow drops to 6,500 (-18%), PFE is predicted to fall to 71 (a 4% decline over 1997).

Conclusion

As expected, it has been proven that the direction of PFE is directly correlated to the direction of the Dow. In the current Model, approximately 30% of the PFE trend is related to changes in the Dow. However, an additional 50% of the PFE trend is related to Big Pharma trends...which in turn are related to changes in the Dow. For PFE to reach 150 in 1998, the Dow would need to jump to 12,000 (a 52% increase over 1997).

Comments and suggestions are always welcome!!!

Have PFun!

BigKNY3